| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |